ABBOTT LABS/ US0028241000 /
31/05/2024 08:01:32 | Chg. -0.780 | Volume | Bid22:00:01 | Ask22:00:01 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
93.570EUR | -0.83% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 163.9 bill.EUR | - | - |
GlobeNewswire
09/05
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
25/03
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
15/03
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
14/11/2023
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
19/10/2023
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
GlobeNewswire
10/10/2023
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
GlobeNewswire
02/10/2023
Apnimed Adds Independent Director Paul Fonteyne, MS, MBA to Board of Directors
GlobeNewswire
06/09/2023
Endexx Corporation Appoints Ahmed Itani to Director of Marketing of HYLA in The Middle East Region